Our data have revealed that azurocidin may be a potential biomarker candidate for the early detection of periodontal destruction by the inflammation in gingivitis and some chronic periodontitis based on the mass spectrometry, western blot and ELISA data using GCF samples. This evidence concerns the gene AZU1 and chronic periodontitis.